HealthcareBioCardia shares climb as it gets FDA clearance for its Morph DNA product familyBy Helitra.com·August 30, 2024·1 min read BioCardia shares climb as it gets FDA clearance for its Morph DNA product family Source: SeekingalphaADVERTISEMENT ADVERTISEMENTBioCardia clearance climb DNA family FDA Morph product shares Post navigation Previous storyNuvectis gains on FDA’s orphan drug designation for cancer therapyNext storyAmerican Diversified to cancel 142M shares
Fitness · HealthcareLosing Weight on a GLP-1? Here’s What Your Scale Isn’t Telling YouOctober 29, 2026Sponsored by Hume. Watching the number on the scale go down can feel encouraging, especially when weight loss is one of your health…
Fitness · HealthcarePodiatrists Warn Over 60s: Ditch Crocs for Better Foot Support and StabilityOctober 29, 2026There’s a reason so many people reach for the same pair of shoes day after day. When something is easy to slip on,…
Fitness · HealthcareThis Trichologist Has Never Seen So Much Hairline Thinning—and Says One Trendy Hairstyle Could Be to BlameOctober 29, 2026My messy millennial top knot has recently morphed into a slick-back, thanks to my cute Gen Z coworkers. After wearing it a few…